翻訳と辞書 ・ Glubbdubdrib ・ Glubbslyme ・ Glubochek ・ Glubokoye District ・ Gluboky ・ Gluboky, Russia ・ Glucagon ・ Glucagon receptor ・ Glucagon receptor family ・ Glucagon rescue ・ Glucagon-like peptide 1 receptor ・ Glucagon-like peptide 2 receptor ・ Glucagon-like peptide receptor ・ Glucagon-like peptide-1 ・ Glucagon-like peptide-1 agonist ・ Glucagon-like peptide-2 ・ Glucagonoma ・ Glucal ・ Glucan ・ Glucan 1,3-alpha-glucosidase ・ Glucan 1,3-beta-glucosidase ・ Glucan 1,4-a-glucosidase ・ Glucan 1,4-alpha-maltohexaosidase ・ Glucan 1,4-alpha-maltohydrolase ・ Glucan 1,4-alpha-maltotetraohydrolase ・ Glucan 1,4-alpha-maltotriohydrolase ・ Glucan 1,4-beta-glucosidase ・ Glucan 1,6-a-glucosidase ・ Glucan 1,6-alpha-isomaltosidase ・ Glucan endo-1,2-beta-glucosidase
|
|
Glucagon-like peptide-2 : ウィキペディア英語版 | Glucagon-like peptide-2 Glucagon-like peptide-2 (GLP-2) is a 33 amino acid peptide with the sequence HADGSFSDEMNTILDNLAARDFINWLIQTKITD (see Proteinogenic amino acid) in humans. GLP-2 is created by specific post-translational proteolytic cleavage of proglucagon in a process that also liberates the related glucagon-like peptide-1 (GLP-1). GLP-2 is produced by the intestinal endocrine L cell and by various neurons in the central nervous system. Intestinal GLP-2 is co-secreted along with GLP-1 upon nutrient ingestion. When externally administered, GLP-2 produces a number of effects in humans and rodents, including intestinal growth, enhancement of intestinal function, reduction in bone breakdown and neuroprotection. GLP-2 may act in an endocrine fashion to link intestinal growth and metabolism with nutrient intake. GLP-2 and related analogs may be treatments for short bowel syndrome, Crohn's disease, osteoporosis and as adjuvant therapy during cancer chemotherapy. ==See also==
* Glucagon-like peptide 2 receptor
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Glucagon-like peptide-2」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|